Severity of non-immune hydrops fetalis at birth continues to predict survival despite advances in perinatal care

J.H. Simpson, H. McDevitt, D. Young, A.D. Cameron

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)


To describe the aetiology and short-term outcome of live-born infants with non-immune hydrops fetalis (NIH), to identify predictors of mortality and to establish whether there has been any change in mortality over a 14-year period. A retrospective case note review of all liveborn neonates with NIH. 30 infants were identified. Twenty (66%) had an identifiable aetiology. Ten (33%) survived to discharge. Survivors had significantly higher Apgar scores at 1 and 5 min (both p<0.001). Mortality did not differ between the time periods 1990-1999 and 2000-2004. NIH continues to be associated with a significant mortality despite advances in perinatal care. Poor condition at birth is a strong predictor of death.
Original languageEnglish
Pages (from-to)380-382
Number of pages3
JournalFetal diagnosis and therapy
Issue number4
Publication statusPublished - 1 Jun 2006


  • female
  • gestational age
  • humans
  • hydrops fetalis
  • infant mortality
  • newborn infant
  • perinatal care
  • pregnancy

Cite this